MH Innov' is the corporate venture capital fund of the Malakoff Humanis Group, launched in 2018 with a capital of 250 million euros. It invests in innovative startups shaping the future of health and insurance, supporting about 30 startups…Read full bio
1 fund tracked, 12 portfolio companies (10 active · 2 realized). Verified weekly from public filings and deal announcements.
MH Innov' is the corporate venture capital fund of the Malakoff Humanis Group, launched in 2018 with €250 million of capital. The fund invests in innovative startups shaping the future of health and insurance, supporting approximately 30 startups and collaborating with the Malakoff Humanis health and protection insurance ecosystem from Paris.
MH Innov' targets European startups across HealthTech, InsurTech, digital health and selective wellness verticals aligned with Malakoff Humanis's core health and protection insurance mandate. The corporate VC structure provides strategic relationships with one of France's largest health insurance groups, supporting portfolio company commercial development with French insurance distribution and health partner networks. Equity tickets vary by stage from venture-stage early commitments through to growth-stage follow-on investments.
Recent realised exits include CetteFamille (healthcare, 2025) and Health for People (healthcare, 2024), reflecting selective distribution across the corporate VC portfolio. The platform tracks a single dedicated fund and 10 active portfolio companies across the health-themed venture programme. Detailed buyer names and multiple data available on Pro at €49/month.
Other private equity firms tracked on GP Intel.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in